United Therapeutics Corporation Common Stock UTHR
i
Market dataready · fetched 2026-11-11T15:52:48.422Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-11T15:52:08.512716293Z
FundamentalsSEC EDGAR · ready · as of 2026-09-30 · fetched 2026-11-11T15:52:47.806147+00:00
United Therapeutics Corporation Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 618.88 | 32.7% | 5.2% | 561.73 | 40.8% | 5.7% |
| 25Δ | 613.42 | 32.2% | 4.5% | 568.66 | 39.2% | 4.8% |
| 30Δ | 608.33 | 31.6% | 3.8% | 575.11 | 35.8% | 3.8% |
| 35Δ | 603.84 | 30.6% | 3.2% | 580.90 | 32.7% | 3.0% |
| 40Δ | 599.48 | 29.9% | 2.7% | 584.83 | 32.1% | 2.6% |
| 45Δ | 595.93 | 31.3% | 2.5% | 588.76 | 31.6% | 2.2% |
| 50Δ | 592.37 | 32.7% | 2.2% | 592.52 | 31.3% | 1.8% |
| 55Δ | 588.65 | 33.7% | 2.0% | 596.20 | 31.2% | 1.5% |
| 60Δ | 584.59 | 33.9% | 1.7% | 599.88 | 31.1% | 1.3% |
| 65Δ | 580.53 | 34.0% | 1.4% | 604.29 | 31.7% | 1.1% |
| 70Δ | 576.16 | 33.9% | 1.1% | 608.73 | 32.4% | 0.8% |
| 75Δ | 571.75 | 33.6% | 0.9% | 613.99 | 33.0% | 0.7% |
| 80Δ | 566.07 | 34.3% | 0.7% | 619.58 | 33.6% | 0.5% |
20Δ
- Pseudo strike
- 618.88
- IV
- 32.7%
- B/E move
- 5.2%
- Pseudo strike
- 561.73
- IV
- 40.8%
- B/E move
- 5.7%
25Δ
- Pseudo strike
- 613.42
- IV
- 32.2%
- B/E move
- 4.5%
- Pseudo strike
- 568.66
- IV
- 39.2%
- B/E move
- 4.8%
30Δ
- Pseudo strike
- 608.33
- IV
- 31.6%
- B/E move
- 3.8%
- Pseudo strike
- 575.11
- IV
- 35.8%
- B/E move
- 3.8%
35Δ
- Pseudo strike
- 603.84
- IV
- 30.6%
- B/E move
- 3.2%
- Pseudo strike
- 580.90
- IV
- 32.7%
- B/E move
- 3.0%
40Δ
- Pseudo strike
- 599.48
- IV
- 29.9%
- B/E move
- 2.7%
- Pseudo strike
- 584.83
- IV
- 32.1%
- B/E move
- 2.6%
45Δ
- Pseudo strike
- 595.93
- IV
- 31.3%
- B/E move
- 2.5%
- Pseudo strike
- 588.76
- IV
- 31.6%
- B/E move
- 2.2%
50Δ
- Pseudo strike
- 592.37
- IV
- 32.7%
- B/E move
- 2.2%
- Pseudo strike
- 592.52
- IV
- 31.3%
- B/E move
- 1.8%
55Δ
- Pseudo strike
- 588.65
- IV
- 33.7%
- B/E move
- 2.0%
- Pseudo strike
- 596.20
- IV
- 31.2%
- B/E move
- 1.5%
60Δ
- Pseudo strike
- 584.59
- IV
- 33.9%
- B/E move
- 1.7%
- Pseudo strike
- 599.88
- IV
- 31.1%
- B/E move
- 1.3%
65Δ
- Pseudo strike
- 580.53
- IV
- 34.0%
- B/E move
- 1.4%
- Pseudo strike
- 604.29
- IV
- 31.7%
- B/E move
- 1.1%
70Δ
- Pseudo strike
- 576.16
- IV
- 33.9%
- B/E move
- 1.1%
- Pseudo strike
- 608.73
- IV
- 32.4%
- B/E move
- 0.8%
75Δ
- Pseudo strike
- 571.75
- IV
- 33.6%
- B/E move
- 0.9%
- Pseudo strike
- 613.99
- IV
- 33.0%
- B/E move
- 0.7%
80Δ
- Pseudo strike
- 566.07
- IV
- 34.3%
- B/E move
- 0.7%
- Pseudo strike
- 619.58
- IV
- 33.6%
- B/E move
- 0.5%
Options history
Table
| Date | IV (%) |
|---|---|
| 32.40% | |
| 31.28% | |
| 33.84% | |
| 34.06% | |
| 35.67% | |
| 38.51% | |
| 33.33% | |
| 33.55% | |
| 32.89% | |
| 32.83% | |
| 32.51% | |
| 32.98% | |
| 32.65% | |
| 33.03% | |
| 34.15% | |
| 34.72% | |
| 34.28% | |
| 35.59% | |
| 34.62% | |
| 35.56% | |
| 33.12% | |
| 36.08% | |
| 37.49% | |
| 37.96% | |
| 38.42% | |
| 33.59% | |
| 32.22% | |
| 32.99% | |
| 32.21% | |
| 33.75% | |
| 33.60% | |
| 33.57% | |
| 33.02% | |
| 34.16% | |
| 34.01% | |
| 33.39% | |
| 33.64% | |
| 33.89% | |
| 35.80% | |
| 37.12% | |
| 34.66% | |
| 35.79% | |
| 36.73% | |
| 37.02% | |
| 37.67% | |
| 34.90% | |
| 33.80% | |
| 33.74% | |
| 32.94% | |
| 34.32% | |
| 34.96% | |
| 34.84% | |
| 34.97% | |
| 34.41% | |
| 33.00% | |
| 35.67% |
Drug Manufacturers - Specialty & Generic
VTRS
Viatris Inc. is an American global healthcare company headquartered in Canonsburg, Pennsylvania.
More →XERS
Xeris Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and markets ready-to-use injectable and infusible drug formulations. The company is headquartered in…
More →ZTS
Zoetis Inc. is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock.
More →ACB
Aurora Cannabis Inc. produces and distributes medical cannabis products globally. The company is headquartered in Edmonton, Canada.
More →AKBA
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of kidney therapies for patients with kidney disease. The company is…
More →ALKS
Description unavailable
More →